Annual Cash & Cash Equivalents
$1.05 B
-$2.37 B-69.29%
December 31, 2023
Summary
- As of February 7, 2025, BIIB annual cash & cash equivalents is $1.05 billion, with the most recent change of -$2.37 billion (-69.29%) on December 31, 2023.
- During the last 3 years, BIIB annual cash & cash equivalents has fallen by -$281.30 million (-21.13%).
- BIIB annual cash & cash equivalents is now -69.29% below its all-time high of $3.42 billion, reached on December 31, 2022.
Performance
BIIB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.70 B
-$209.70 M-10.99%
September 30, 2024
Summary
- As of February 7, 2025, BIIB quarterly cash and cash equivalents is $1.70 billion, with the most recent change of -$209.70 million (-10.99%) on September 30, 2024.
- Over the past year, BIIB quarterly cash and cash equivalents has dropped by -$209.70 million (-10.99%).
- BIIB quarterly cash and cash equivalents is now -58.64% below its all-time high of $4.11 billion, reached on March 31, 2018.
Performance
BIIB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIIB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.3% | -11.0% |
| 3 y3 years | -21.1% | -11.0% |
| 5 y5 years | -14.3% | -11.0% |
BIIB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.3% | at low | -53.8% | +61.8% |
| 5 y | 5-year | -69.3% | at low | -53.8% | +61.8% |
| alltime | all time | -69.3% | +8232.5% | -58.6% | >+9999.0% |
Biogen Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.70 B(-11.0%) |
| Jun 2024 | - | $1.91 B(+77.7%) |
| Mar 2024 | - | $1.07 B(+2.3%) |
| Dec 2023 | $1.05 B(-69.3%) | $1.05 B(-54.1%) |
| Sep 2023 | - | $2.29 B(-12.6%) |
| Jun 2023 | - | $2.62 B(-9.7%) |
| Mar 2023 | - | $2.90 B(-15.2%) |
| Dec 2022 | $3.42 B(+51.2%) | $3.42 B(-7.0%) |
| Sep 2022 | - | $3.68 B(+38.9%) |
| Jun 2022 | - | $2.65 B(+51.3%) |
| Mar 2022 | - | $1.75 B(-22.6%) |
| Dec 2021 | $2.26 B(+69.9%) | $2.26 B(+46.7%) |
| Sep 2021 | - | $1.54 B(-11.5%) |
| Jun 2021 | - | $1.74 B(+43.1%) |
| Mar 2021 | - | $1.22 B(-8.5%) |
| Dec 2020 | $1.33 B(-54.3%) | $1.33 B(-40.2%) |
| Sep 2020 | - | $2.22 B(-6.7%) |
| Jun 2020 | - | $2.38 B(-8.0%) |
| Mar 2020 | - | $2.59 B(-11.1%) |
| Dec 2019 | $2.91 B(+137.9%) | $2.91 B(+24.3%) |
| Sep 2019 | - | $2.34 B(+36.0%) |
| Jun 2019 | - | $1.72 B(-23.2%) |
| Mar 2019 | - | $2.24 B(+83.2%) |
| Dec 2018 | $1.22 B(-22.2%) | $1.22 B(-48.7%) |
| Sep 2018 | - | $2.39 B(+90.9%) |
| Jun 2018 | - | $1.25 B(-69.6%) |
| Mar 2018 | - | $4.11 B(+161.0%) |
| Dec 2017 | $1.57 B(-32.4%) | $1.57 B(+1.7%) |
| Sep 2017 | - | $1.55 B(+32.4%) |
| Jun 2017 | - | $1.17 B(+26.6%) |
| Mar 2017 | - | $924.00 M(-60.3%) |
| Dec 2016 | $2.33 B(+77.9%) | $2.33 B(+11.6%) |
| Sep 2016 | - | $2.08 B(+53.1%) |
| Jun 2016 | - | $1.36 B(+20.5%) |
| Mar 2016 | - | $1.13 B(-13.6%) |
| Dec 2015 | $1.31 B(+8.6%) | $1.31 B(-68.0%) |
| Sep 2015 | - | $4.09 B(+218.9%) |
| Jun 2015 | - | $1.28 B(-13.3%) |
| Mar 2015 | - | $1.48 B(+22.7%) |
| Dec 2014 | $1.20 B(+100.0%) | $1.20 B(+1.6%) |
| Sep 2014 | - | $1.19 B(+37.4%) |
| Jun 2014 | - | $863.20 M(+4.2%) |
| Mar 2014 | - | $828.60 M(+37.5%) |
| Dec 2013 | $602.56 M(+5.6%) | $602.56 M(+40.8%) |
| Sep 2013 | - | $427.81 M(+9.0%) |
| Jun 2013 | - | $392.51 M(-40.8%) |
| Mar 2013 | - | $663.30 M(+16.2%) |
| Dec 2012 | $570.72 M(+10.9%) | $570.72 M(+26.3%) |
| Sep 2012 | - | $451.72 M(-1.1%) |
| Jun 2012 | - | $456.81 M(+53.2%) |
| Mar 2012 | - | $298.14 M(-42.1%) |
| Dec 2011 | $514.54 M(-32.3%) | $514.54 M(-10.5%) |
| Sep 2011 | - | $575.14 M(-17.5%) |
| Jun 2011 | - | $697.53 M(-11.8%) |
| Mar 2011 | - | $790.67 M(+4.1%) |
| Dec 2010 | $759.60 M(+30.5%) | $759.60 M(+21.2%) |
| Sep 2010 | - | $626.76 M(-13.1%) |
| Jun 2010 | - | $720.96 M(+12.7%) |
| Mar 2010 | - | $639.56 M(+9.9%) |
| Dec 2009 | $581.89 M(-6.5%) | $581.89 M(-0.7%) |
| Sep 2009 | - | $585.79 M(-25.5%) |
| Jun 2009 | - | $786.80 M(+3.0%) |
| Mar 2009 | - | $764.10 M(+22.8%) |
| Dec 2008 | $622.38 M(-5.7%) | $622.38 M(-38.4%) |
| Sep 2008 | - | $1.01 B(+116.7%) |
| Jun 2008 | - | $466.49 M(-32.2%) |
| Mar 2008 | - | $688.50 M(+4.4%) |
| Dec 2007 | $659.66 M(-0.3%) | $659.66 M(+50.8%) |
| Sep 2007 | - | $437.33 M(-72.9%) |
| Jun 2007 | - | $1.61 B(+106.4%) |
| Mar 2007 | - | $780.94 M(+18.1%) |
| Dec 2006 | $661.38 M | $661.38 M(+59.5%) |
| Sep 2006 | - | $414.59 M(+20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $345.10 M(-35.6%) |
| Mar 2006 | - | $535.87 M(-5.7%) |
| Dec 2005 | $568.17 M(+171.3%) | $568.17 M(+91.6%) |
| Sep 2005 | - | $296.49 M(-53.6%) |
| Jun 2005 | - | $638.40 M(+130.9%) |
| Mar 2005 | - | $276.44 M(+32.0%) |
| Dec 2004 | $209.45 M(-33.5%) | $209.45 M(+17.0%) |
| Sep 2004 | - | $179.02 M(-63.0%) |
| Jun 2004 | - | $483.31 M(+59.6%) |
| Mar 2004 | - | $302.79 M(-3.8%) |
| Dec 2003 | $314.85 M(-10.1%) | $314.85 M(+175.3%) |
| Sep 2003 | - | $114.36 M(+84.0%) |
| Jun 2003 | - | $62.15 M(+71.4%) |
| Mar 2003 | - | $36.26 M(-89.6%) |
| Dec 2002 | $350.13 M(+547.9%) | $350.13 M(+593.2%) |
| Sep 2002 | - | $50.51 M(+67.0%) |
| Jun 2002 | - | $30.23 M(-68.0%) |
| Mar 2002 | - | $94.52 M(+74.9%) |
| Dec 2001 | $54.04 M(+10.9%) | $54.04 M(-9.3%) |
| Sep 2001 | - | $59.61 M(-21.5%) |
| Jun 2001 | - | $75.97 M(+167.0%) |
| Mar 2001 | - | $28.45 M(-41.6%) |
| Dec 2000 | $48.74 M(-14.4%) | $48.74 M(+36.0%) |
| Sep 2000 | - | $35.85 M(-46.9%) |
| Jun 2000 | - | $67.46 M(-33.9%) |
| Mar 2000 | - | $102.04 M(+79.3%) |
| Dec 1999 | $56.92 M(+123.7%) | $56.92 M(-22.6%) |
| Sep 1999 | - | $73.50 M(+39.5%) |
| Jun 1999 | - | $52.70 M(-42.3%) |
| Mar 1999 | - | $91.40 M(+259.2%) |
| Dec 1998 | $25.45 M(-63.8%) | $25.45 M(-73.0%) |
| Sep 1998 | - | $94.20 M(+31.2%) |
| Jun 1998 | - | $71.80 M(+9.5%) |
| Mar 1998 | - | $65.60 M(-6.8%) |
| Dec 1997 | $70.36 M(+13.4%) | $70.36 M(+12.4%) |
| Sep 1997 | - | $62.60 M(-14.6%) |
| Jun 1997 | - | $73.30 M(-27.8%) |
| Mar 1997 | - | $101.50 M(+63.6%) |
| Dec 1996 | $62.03 M(+35.5%) | $62.03 M(-0.9%) |
| Sep 1996 | - | $62.60 M(+25.0%) |
| Jun 1996 | - | $50.10 M(+54.2%) |
| Mar 1996 | - | $32.50 M(-29.0%) |
| Dec 1995 | $45.77 M(-16.3%) | $45.77 M(-12.8%) |
| Sep 1995 | - | $52.50 M(+12.4%) |
| Jun 1995 | - | $46.70 M(-31.7%) |
| Mar 1995 | - | $68.40 M(+25.1%) |
| Dec 1994 | $54.68 M(-26.6%) | $54.68 M(-16.5%) |
| Sep 1994 | - | $65.50 M(+67.5%) |
| Jun 1994 | - | $39.10 M(-25.8%) |
| Mar 1994 | - | $52.70 M(-29.3%) |
| Dec 1993 | $74.50 M(-13.3%) | $74.50 M(-0.5%) |
| Sep 1993 | - | $74.90 M(-3.0%) |
| Jun 1993 | - | $77.20 M(+62.9%) |
| Mar 1993 | - | $47.40 M(-44.8%) |
| Dec 1992 | $85.90 M(+51.8%) | $85.90 M(+13.9%) |
| Sep 1992 | - | $75.40 M(+104.9%) |
| Jun 1992 | - | $36.80 M(-5.2%) |
| Mar 1992 | - | $38.80 M(-31.4%) |
| Dec 1991 | $56.60 M(+349.2%) | $56.60 M(+177.5%) |
| Sep 1991 | - | $20.40 M(+482.9%) |
| Jun 1991 | - | $3.50 M(-79.5%) |
| Mar 1991 | - | $17.10 M(+35.7%) |
| Dec 1990 | $12.60 M(-62.0%) | $12.60 M(-13.1%) |
| Sep 1990 | - | $14.50 M(-15.7%) |
| Jun 1990 | - | $17.20 M(+20.3%) |
| Mar 1990 | - | $14.30 M(-56.9%) |
| Dec 1989 | $33.20 M(-38.9%) | $33.20 M(+2.8%) |
| Sep 1989 | - | $32.30 M(-40.5%) |
| Dec 1988 | $54.30 M(-0.2%) | $54.30 M(-0.2%) |
| Dec 1987 | $54.40 M(-22.8%) | $54.40 M(-22.8%) |
| Dec 1986 | $70.50 M(+31.8%) | $70.50 M(+31.8%) |
| Dec 1985 | $53.50 M(-28.6%) | $53.50 M(-28.6%) |
| Dec 1984 | $74.90 M | $74.90 M |
FAQ
- What is Biogen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Biogen?
- What is Biogen annual cash & cash equivalents year-on-year change?
- What is Biogen quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Biogen?
- What is Biogen quarterly cash and cash equivalents year-on-year change?
What is Biogen annual cash & cash equivalents?
The current annual cash & cash equivalents of BIIB is $1.05 B
What is the all time high annual cash & cash equivalents for Biogen?
Biogen all-time high annual cash & cash equivalents is $3.42 B
What is Biogen annual cash & cash equivalents year-on-year change?
Over the past year, BIIB annual cash & cash equivalents has changed by -$2.37 B (-69.29%)
What is Biogen quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BIIB is $1.70 B
What is the all time high quarterly cash and cash equivalents for Biogen?
Biogen all-time high quarterly cash and cash equivalents is $4.11 B
What is Biogen quarterly cash and cash equivalents year-on-year change?
Over the past year, BIIB quarterly cash and cash equivalents has changed by -$209.70 M (-10.99%)